The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction
Open accessAbstract
T cells become dysfunctional when they encounter self antigens or are exposed to chronic infection or to the tumour microenvironment 1. The function of T cells is tightly regulated by a combinational co-stimulatory signal, and dominance of negative co-stimulation results in T cell dysfunction 2. However, the molecular mechanisms that underlie this dysfunction remain unclear. Here, using an in vitro T cell tolerance induction system in mice, we characterize genome-wide epigenetic and gene expression features in tolerant T cells, and show that they are distinct from effector and regulatory T cells. Notably, the transcription factor NR4A1 is stably expressed at high levels in tolerant T cells. Overexpression of NR4A1 inhibits effector T cell differentiation, whereas deletion of NR4A1 overcomes T cell tolerance and exaggerates effector function, as well as enhancing immunity against tumour and chronic virus. Mechanistically, NR4A1 is preferentially recruited to binding sites of the transcription factor AP-1, where it represses effector-gene expression by inhibiting AP-1 function. NR4A1 binding also promotes acetylation of histone 3 at lysine 27 (H3K27ac), leading to activation of tolerance-related genes. This study thus identifies NR4A1 as a key general regulator in the induction of T cell dysfunction, and a potential target for tumour immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Because Nr4a2 is highly related to Nr4a1 and has been found to promote T cell exhaustion (33-35),”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredIn the citing paper
“NFAT-induced transcription factors, including NR4A and TOX, drive T cell exhaustion/dysfunction44–47.”
From Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma (2023) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
Pauken, K. E., Sammons, M. A., Odorizzi, P. M., Manne, S., Godec, J., Khan, O., Drake, A. M., Chen, Z., Sen, D. R., Kurachi, M., et al. (2016) · Science · doi:10.1126/science.aaf2807 · Cited by 1,348
Wei, G., Wei, L., Zhu, J., Zang, C., Hu-Li, J., Yao, Z., Cui, K., Kanno, Y., Roh, T.-Y., Watford, W. T., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.009 · Cited by 1,152
Self-citationThe epigenetic landscape of T cell exhaustion
Sen, D. R., Kaminski, J., Barnitz, R. A., Kurachi, M., Gerdemann, U., Yates, K. B., Tsao, H.-W., Godec, J., LaFleur, M. W., Brown, F. D., et al. (2016) · Science · doi:10.1126/science.aae0491 · Cited by 986
The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells
Martinez, G. J., Pereira, R. M., Äijö, T., Kim, E. Y., Marangoni, F., Pipkin, M. E., Togher, S., Heissmeyer, V., Zhang, Y. C., Crotty, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.006 · Cited by 857
Tolerance and exhaustion: defining mechanisms of T cell dysfunction
Schietinger, A., & Greenberg, P. D. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.10.001 · Cited by 704
Cited by
Sorted by citations
Items 401–500 of 535
Wang, Y., Yang, Y., Yu, W. C., Liu, Y., Guan, W., Wang, Y., Li, N., Cao, L., & Wang, D. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08645-w · Cited by 2
Self-citationJiang, T., Zhou, P., Shen, Y., Lin, J., Li, Y., Shen, X., Fang, L., Xu, P., Xu, Z., Wang, L., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00444-1 · Cited by 2
“Notably, NR4A1 is pivotal for inducing T effector cell dysfunction and fostering an immunosuppressive micro-environment [30, 31], suggesting that ANXA1 + CD8 + T cells are associated with immune suppression.”
Lei, K., Tian, J., Zhang, L., Gong, Z., Liu, W., Wan, Z., Wang, Y., Li, R., Dong, B., & Wang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1784450 · Cited by 2
Self-citationAgesta, A., Ferrand, C., Dorze, A.-L. L., Peillex, C., Carrié, N., Barascud, R., Palak, A., Esteban, L., Bernal, T., Joulia, E., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.05.018 · Cited by 3
Austin, R. J., Kowalski, M. H., Wang, X., Lin, Z., Nadorp, B., Ward, N., Rovatti, P. E., Lasry, A., Sun, Z., Rojo-Tomillo, J., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.08.002 · Cited by 2
Self-citationvan den Broecke, L., der Vreken, A. V., Watté, F., Meeus, F., Veirman, K. D., Breckpot, K., Bruyne, E. D., & Menu, E. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02923-x · Cited by 3
Mi, L., Gong, D., Wang, L., Liang, X., Meng, J., Huang, W., & Zhou, J. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100437 · Cited by 2
Mechanisms of Resistance and Relapse After CAR-T Cell Therapy
Selli, M. E., Dalal, P., Neelapu, S. S., & Singh, N. (2022) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-87849-8_12 · Cited by 2
Intermittent administration of tacrolimus enhances anti-tumor immunity in melanoma-bearing mice
Chen, T., Zhang, Q., Zhang, N., Liu, B., Chen, J., Huang, F., Lin, J., Lan, R., Xie, X., & Wang, Z. (2022) · Carcinogenesis · doi:10.1093/carcin/bgac017 · Cited by 2
Self-citationEl-Helbawy, N. F., & Zowalaty, A. E. E. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44090282 · Cited by 2
Immunotherapy in cancer: Where we are and what the future brings?
Kršek, A., Krpina, K., Miroslav, S., Detel, D., Batičić, L., & Tokmadžić, V. S. (2023) · Trends in Immunotherapy · doi:10.24294/ti.v7.i2.2186 · Cited by 2
“The precise role of LAG-3 in Treg and Tr1 cell activities is still under investigation [122] .”
BackgroundZhou, J., Liu, X., Yin, H., Zhou, Y. F., Xu, Z., Zhou, K., Li, T., Fang, Y., & Shen, Q. (2024) · Gene · doi:10.1016/j.gene.2024.148292 · Cited by 2
Self-citationShen, Y., Luo, B., Zhang, Q., Li, H., Hu, Y. C., & Chen, M. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-95451-7 · Cited by 2
Promoting longevity with less cancer: The 2022 International Conference on Aging and Cancer
Cui, Y., Wang, K., Jiang, D., Jiang, Y.-Z., Shi, D., DeGregori, J. V., Waxman, S., & Ren, R. (2023) · Aging and Cancer · doi:10.1002/aac2.12068 · Cited by 2
“57 Signal transducer and activator of transcription 3 (STAT3) is essential for the differentiation of the TH17 helper T cells.”
BackgroundGuo, X., & Dong, C. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2100-2 · Cited by 2
“…by key transcription factors (TFs) including Tbet, EOMES, NR4A1, TCF1 and TOX, tumor-infiltrating T cells exhibit a significant degree of heterogeneity, from progenitor exhausted T cells (Tex) to terminal Tex (Beltra et al., 2020; Liu et al., 2019; Paley et al., 2012; Utzschneider et al., 2016).”
BackgroundSelf-citationLi, R., Guo, H., Hou, Y., Liu, S., Wang, M., Peng, T., Zhao, X., Lu, L., Han, Y., Shao, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.11.988253 · Cited by 2
“…signals in mice by others (Liu et al., 2019) and treatment of healthy donors with G-CSF in our study (Jun et al., 2004), for tolerance induction via different signaling pathways might lead to differences in gene and TF expression (Liu et al., 2019; Soskic et al., 2019; Zhu and Paul, 2010).”
BackgroundMethodInfluentialChen, Z., Arai, E., Khan, O., Zhang, Z., Ngiow, S. F., He, Y. M., Huang, H., Manne, S., Cao, Z., Baxter, A. E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.20.087379 · Cited by 2
“Genes known to promote T cell exhaustion, like Tox, Nr4a1 and Nr4a2 (Alfei et al., 2019; Chen et al., 2019a; Khan et al., 2019; Liu et al., 2019; Scott et al., 2019; Seo et al., 2019; Yao et al., 2019) were revealed, as was Tcf7 due to its the ability to antagonize T cell activation and TEFF…”
BackgroundSelf-citationSchmassmann, P., Roux, J., Dettling, S., Hogan, S. A., Shekarian, T., Martins, T. A., Ritz, M., Herter, S., Bacac, M., & Hütter, G. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.17.496574 · Cited by 2
Ran, R., Uslu, M., Siddiqui, M. F., Brubaker, D. K., & Trapečar, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.11.642626 · Cited by 2
NR4A1 limits CD8 + T Cell effector responses and protection in tuberculosisPreprint
Singhal, A., Fatima, S., Chen, Y., Smulan, L., Satish, B., Jameson, M., Saini, S., Johnson, C., Tay, A., Foo, S., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8363336/v1 · Cited by 2
Lam, V. C., Barragan, J., Cheung, C., Lü, J., Chian, D., Martinez, R., Sims, C., Sundar, P. D., Hiraragi, H., Potluri, S., et al. (2022) · Regular and Young Investigator Award Abstracts · doi:10.1136/jitc-2022-sitc2022.0243 · Cited by 1
Jin, L., Li, J., & Zhu, F. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2426319 · Cited by 1
“26 The deletion of NR4A1 proves effective in overcoming T cell tolerance and amplifying effector functions.”
InfluentialSelf-citationFunctional Changes Associated With the Subcellular Localization of the Nuclear Receptor NR4A1
Kiriyama, Y., Nakatsuma, A., Tokumaru, H., Sadamoto, H., & Nochi, H. (2025) · Biochemistry Research International · doi:10.1155/bri/4849733 · Cited by 1
Chen, X., Nong, Y., Zhang, M., & Du, C. (2025) · The Journal of Gene Medicine · doi:10.1002/jgm.70037 · Cited by 1
Nr4a1 Deficiency Potentially Promotes Hearing Loss Through Inner Ear Immunity in C57BL/6N Mice
Lai, Y., Wang, X., Wang, M., Su, B., Chu, H., Yang, F., & Bing, D. (2025) · Otology & Neurotology · doi:10.1097/mao.0000000000004625 · Cited by 1
Self-citationChen, Y., Wang, Z., Song, L., Chen, Q., Zhang, H., Pan, T., Pan, J., Zhao, S., Shang, T., Xu, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202512452 · Cited by 2
Self-citationTokushige, K., Yin, E., Yogo, K., Gong, Y., Morimoto, K., Kuriyama, K., Kubo, M., Yagita∥, H., Kitaura, J., Okumura, K., et al. (2025) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.11.017 · Cited by 1
Zhou, L., Li, X., Wu, J., Zheng, T., Lin, M., Ou, Y., Zhou, H., Mo, S., Han, X., Xiang, J., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07559-z · Cited by 1
“The NR4A transcription factor family, which comprises NR4A1, NR4A2, and NR4A3, is known to advance tumor growth by repressing cytokine production [65–67].”
Self-citationNR4A Receptors in Immunity: Bridging Neuroendocrine and Inflammatory Pathways
Santucci, N. E., & Ferreira, S. (2025) · Receptors · doi:10.3390/receptors5010003 · Cited by 1
“Genetic deletion of NR4A1 in T-cells enhances antitumor responses, increasing IL-2 and IFN γ production, together with a reduced PD-1 expression and improving T-cell persistence [51,80].”
InfluentialThe orphan nuclear receptor NR4A3 is dispensable for resident memory CD8+ T-cell generation
Odagiu, L., Boulet, S., Sousa, D. M. D., Daudelin, J., & Labrecque, N. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlaf087 · Cited by 1
“Such an impact on the generation of KLRG1-negative CD8 þ Trm precursors was not observed with Nr4a1 -/- CD8 þ T cells 34 (unpublished observations).”
Ran, R., Uslu, M., Siddiqui, M. F., Brubaker, D. K., & Trapečar, M. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116916 · Cited by 4
“37 We inferred an increase in CTLA4 and tolerance-related transcription factors (TFs) 38,39 NR4A1 and NR4A2, along with a decrease in the calcium-binding protein-encoding genes S100A4, S100A6, and S100A10 and the longevity marker IL7R, when transitioning from liver CD4 + T cells to intraepithelial…”
Peng, Y., Zhong, G., Zhou, M., Yao, Y., Dong, K., Yang, Z., An, L., Zhang, J., Zhang, J., Zhang, S., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1749138 · Cited by 2
Saraç, H., Nicholson, R., Graham, R. N., Augustus, M., Taghavi, R., Connolly, D. J., Lim, L., & Lourenco, S. D. S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1509926 · Cited by 1
Targeting Mettl8-Tcf1 axis promotes CD8+ TPEX differentiation and antitumor immunity
Song, J., Cui, D., Wang, J., Qi, X., Ma, J., Liu, Q., Yang, J., Yu, H., Ye, L., Huang, Q., et al. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20250424 · Cited by 1
“Activated CD8 + T cells initially exhibit low effector functions, which gradually increase to a peak, followed by a decline that ultimately leads to dysfunction (Liu et al., 2019; Rahim et al., 2023; Schietinger et al., 2016).”
Self-citationKrüppel-like factor 2 programs early exhausted T cell states and restrains antiviral immunity
Geng, S., Li, Z., Li, W., Liang, H., Xu, F., Zhang, L., Zhang, W., Tao, S., Wang, Y., Zhou, Y., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.03.029 · Cited by 2
Self-citationChen, S., Zhang, C., Liu, X., Zhu, Y., Niu, C., & Lv, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1833607 · Cited by 1
Self-citationTargeting UBE2F induces a resilience program enhancing CD8 T cell immunity
Ma, X., Guo, H., Jia, Y., Yin, N., & Peng, M. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20252687 · Cited by 1
Cytotoxic CD39 + tumor-associated NK cells respond to NKG2A blockade in lung cancer
Serger, C., Rebuffet, L., Sandholzer, M. T., Rackwitz, W., Fusi, I., Herzig, P., Brüggemann, A., Pawlow, C. A., Chichelnitskiy, E., Hajnal, D., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.aeb6645 · Cited by 3
T Cell Exhaustion as a Regulated Differentiation Programme
Veldhoen, M., & Ferreira, C. (2026) · European Journal of Immunology · doi:10.1002/eji.70205 · Cited by 3
“NR4A1, NR4A2, and NR4A3 repress effector gene expression by binding AP-1 motifs and antagonising AP-1–dependent activation [ 21, 22 ].”
Zhang, Q., Zhang, Y., Sun, H., Li, H., Wang, Y., & Wei, F. (2026) · Journal of Virology · doi:10.1128/jvi.00746-26 · Cited by 1
“Given its known role as a key regulator of T-cell dysfunction (57) and its association with MDSC phenotypes, NR4A1 presents a compelling therapeutic target.”
Self-citationTargeting T-cell exhaustion and tumour immune evasion: a review of emerging strategies
Saltis, L., & Mun, L. J. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156638 · Cited by 1
NR4As apply brakes on the B cell response
Hill, L., & Schwickert, T. A. (2020) · Nature Immunology · doi:10.1038/s41590-020-0775-5 · Cited by 1
A proposal to improve gene expression analysis
Kerachian, M. A., Azghandi, M., & Thiery, J. P. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.26 · Cited by 1
Tong, X., & Shen, Q. (2024) · International Ophthalmology · doi:10.1007/s10792-024-03017-9 · Cited by 1
“Studies have also shown that NR4A1 is a key TF that induces T cell dysfunction and may be a feasible target for the treat-ment of autoimmune diseases [32, 33].”
Yang, Q., Patrick, M. S., Lü, J., Chen, J., Zhang, Y., Hemani, H., Lehrmann, E., De, S., & Weng, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1360229 · Cited by 1
Bariana, M., Anand, S. R., Batistick, M., Cassella, E., Anuncio, S. A., Aptekmann, A. A., Siegel, D. S. D., Oelke, M., Kim, S., Wang, R., et al. (2025) · Blood Immunology & Cellular Therapy · doi:10.1016/j.bict.2025.100002 · Cited by 1
Xiao, B., Zhang, Y., Liu, S., Ding, J., Yu, Z., Wang, T., & Song, B. (2020) · Transplantation Proceedings · doi:10.1016/j.transproceed.2020.08.023 · Cited by 1
Xu, J., Shi, J., Cai, X., Huang, S., Li, G., & Xu, Y. (2021) · PubMed Central · doi:10.12122/j.issn.1673-4254.2021.02.06 · Cited by 1
Impaired tumor death receptor signaling drives resistance to CAR T cell therapyPreprint
Singh, N., Shestova, O. E., Ravikumar, P., Hayer, K. E., Hong, S. J., Orlando, E. J., Mueller, K. T., Good, C. R., Berger, S. L., Shalem, O., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/627562 · Cited by 1
A Novel Role for the Nuclear Receptor, NR4A1, in Klebsiella pneumoniae Lung InfectionPreprint
Partyka, J., Henkel, M., & Campfield, B. T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.03.282475 · Cited by 1
Brooks, J. F., Tan, C., Mueller, J. L., Hibiya, K., Hiwa, R., & Zikherman, J. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3773787 · Cited by 1
Meednu, N., Rangel‐Moreno, J., Zhang, F., Escalera-Rivera, K., Corsiero, E., Prediletto, E., DiCarlo, E. F., Goodman, S. M., Donlin, L. T., Raychaudhuri, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.14.443150 · Cited by 1
Haber, D. A., Guo, H., Golczer, G., Wittner, B. S., Langenbucher, A., Zachariah, M. A., Dubash, T. D., Hong, X., Comaills, V., Burr, R., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-84947/v1 · Cited by 1
Voda, A.-I., Correa, K., Hamp, J., Moscrop, C., Dustin, M. L., & Jostins-Dean, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.23.517727 · Cited by 1
“[41] Liu, X, Wang, Y, Lu, H, Li, J, Yan, X, Xiao, M, .”
BackgroundSchmassmann, P., Roux, J., Dettling, S., Hogan, S. A., Shekarian, T., Martins, T. A., Ritz, M., Herter, S., Bacac, M., & Hütter, G. (2023) · eLife · doi:10.7554/elife.92678.1 · Cited by 1
Mogus, J. P., Marin, M., Arowolo, O. K., Salemme, V., & Suvorov, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.04.574224 · Cited by 1
Porte, A. L., Pathak, R., Eliscovich, C., Martins, L. J., Nell, R., Spivak, A. M., Suzuki, M., Planelles, V., Singer, R. H., & Kalpana, G. V. (2024) · Research Square · doi:10.21203/rs.3.rs-4166090/v1 · Cited by 1
Fujisawa, S., Tanabe, Y., Hojo, A., Shiga, R., Kurachi, J., Koura, M., Tamai, T., Miyanari, Y., Wherry, E. J., & Kurachi, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.21.605975 · Cited by 1
Fumagalli, M., An, D., Simula, L., Combe, C., Aziez, L., Simoni, Y., Alves‐Guerra, M., Valentini, A., Marchais, M., Vermare, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.28.645780 · Cited by 1
Morse, M., Rodriguez, X., DeLaRosa, E., Rodriguez, S. G., Shanil, J., & Sinha, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.09.663913 · Cited by 1
Serger, C., Rebuffet, L., Sandholzer, M. T., Fusi, I., Oelgarth, N., Tundo, S., Luu, T. T., Hojski, A., Lardinois, D., Trefny, M. P., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5356127 · Cited by 1
Espinoza, A., Silva, B. J. D. A., & Pellegrini, M. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.02.748788 · Cited by 1
Nguyen, J., Pettmann, J., Kruger, P., & Dushek, O. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.02.450833
“Alternatively, ‘armored’ CAR T cells engineered to inducibly produce pro-inflammatory cytokines in order to adjust the tumour microenvironment in their favour have been proposed (53).”
Background[The direct isotopic cystography in the study of the vesico-ureteral reflux (author's transl)].
Cortázar, J. C. F., González, J. S., Terol, M. C. C., Monfort, J. A., & Marti, I. Z. (1978) · PubMed
Hu, J., zhang, L., Xia, H., Yan, Y., Zhu, X., Sun, F., Sun, L., Li, S., Li, D., Wang, J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-934132/v1
Mohankumar, K., Wright, G. A., Kumaravel, S., Shrestha, R., Abdelrahim, M., Chapkin, R. S., & Safe, S. H. (2021) · Regular and Young Investigator Award Abstracts · doi:10.1136/jitc-2021-sitc2021.732
“fied NR4A1 as a key mediator of T-cell dysfunction and NR4A1 also plays an important role in regulating genes which are involved in tumor-induced T-cell exhaustion.(9) Bis-indole”
BackgroundCD69-OxLDL Ligand Engagement Induces Programmed Cell Death 1 (PD-1) Expression in T LymphocytesPreprint
Jiménez-Fernández, M., Rodriguez-Sinovas, C., Cañes, L., Ballester‐Servera, C., Vara, A., Requena, S., de la Fuente, H., Martínez‐González, J., & Sánchez‐Madrid, F. (2022) · Research Square · doi:10.21203/rs.3.rs-1373760/v1
Riegel, D., Romero-Fernández, E., Simon, M., Adenugba, A. R., Singer, K., Mayr, R., Weber, F., Imbusch, C. D., Kreutz, M. P., Brors, B., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.16.484513
Pawelec, G. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737026147.793569308
(2022) · Science China Life Sciences · doi:10.1007/s11427-022-2101-x
“Dr. Dong’s group has ongoing research to understand the molecular mechanisms of CD8+ T cell dysfunction in cancer, and has shown critical roles for Eomes (Li et al., 2018a) and Nr4a1 (Liu et al., 2019) transcription factors.”
BackgroundIntroduction: Redefining T-cell Exhaustion Special Issue
Kagoya, Y., & Togashi, Y. (2022) · International Immunology · doi:10.1093/intimm/dxac043
NR4A3 deficiency in CD8 + T cells improves adoptive T cell therapy of cancerPreprint
Odagiu, L., Mezrag, S., Sousa, D. M. D., Boulet, S., & Labrecque, N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.21.537841
Voda, A.-I., Correa, K., Hamp, J., Moscrop, C., Dustin, M. L., & Jostins-Dean, L. (2023) · doi:10.7554/elife.86891.1
Voda, A.-I., Correa, K., Hamp, J., Moscrop, C., Dustin, M. L., & Jostins-Dean, L. (2023) · doi:10.7554/elife.86891
Liu, Q., Liu, H., Xu, C., Shi, J., Xie, Y., Hu, S., & Han, G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.14.548972
“Unraveling their functions is crucial for elucidating the basic principles of life, investigating biological development and evolution, and uncovering the underlying mechanisms of disease occurrence[2, 4].”
BackgroundUnleashing the Power of NR4A1 Degradation as a Novel Strategy for Cancer ImmunotherapyPreprint
Wang, L. A., Xiao, Y., Luo, Y., Master, R. P., Mo, J., Kim, M., Liu, Y., Patel, U. M., Li, X., Shaffer, D. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.09.552650
Zhou, J., Liu, X., Yin, H., Zhou, Y. F., Xu, Z., Zhou, K., Li, T., Fang, Y., & Shen, Q. (2023) · Research Square · doi:10.21203/rs.3.rs-3350840/v1
Self-citationHu, J., Zhang, L., Xia, H., Yan, Y., Zhu, X., Sun, F., Sun, L., Li, S., Li, D., Wang, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22617403
Hu, J., Zhang, L., Xia, H., Yan, Y., Zhu, X., Sun, F., Sun, L., Li, S., Li, D., Wang, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22617394
Hu, J., Zhang, L., Xia, H., Yan, Y., Zhu, X., Sun, F., Sun, L., Li, S., Li, D., Wang, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22617406
Schmassmann, P., Roux, J., Dettling, S., et al. (2023) · eLife · doi:10.7554/elife.92678.1.sa0
Transcriptional control of central T cell tolerance by NR4A family nuclear receptorsPreprint
Nielsen, H. V., Mueller, J. L., Hiwa, R., Yang, L., Proekt, I., Rackaityte, E., Aylard, D. A., Scharer, C. D., Anderson, M. S., Au‐Yeung, B. B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.19.594881
Semitekolou, M., Paschalidis, N., Tartaro, D. L., Tsitsopoulou, A., Stamou, P., Mavroudis, A., Markaki, E., Varveri, A., Morianos, I., Lavigne, M. D., et al. (2024) · medRxiv · doi:10.1101/2024.08.27.24312529
“PD-L1 + CD8 + T cells expressed higher levels of genes associated with T cell immune suppression or exhaustion, including NR4A1, IGFBP2 and LAYN 29-31 , ( Fig.”
BackgroundResultInfluentialA lymphoid tissue chemokine checkpoint prevents loss of CD8 + T cell functionalityPreprint
Altenburger, L. M., Carvoeiro, D. C., Dehio, P., Zhou, J., Laura, C., Katoch, M., Krueger, C., de Albuquerque, J. B., Pfenninger, P., Magdaleno, J. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.19.613830
Zhang, Y., Cheng, J., Jin, P., Lv, L., Yu, H., Yang, C., & Zhang, S. (2024) · Technology and Health Care · doi:10.1177/09287329241290937
Phenotypic Heterogeneity of Dysfunctional Natural Killer Cells During Chronic Infection or Cancer
Pouxvielh, K., Marotel, M., Rousseaux, N., Picq, L., Benezech, S., Nombel, A., Kern, N., Marçais, A., & Walzer, T. (2025) · Springer eBooks · doi:10.1007/978-3-662-68816-8_30-1
Shi, J., & Lü, B. (2024) · PubMed Central · doi:10.11817/j.issn.1672-7347.2024.240220
“Additionally, professor DONG Chen and QI Hai [50-53] , 2 Chinese scholars, have achieved internationally leading research outcomes in adaptive immunity, particularly in studies of T and B lymphocytes, closely related to late-stage immune suppression in critical illness.”
Multi-omics for disease subtyping and classification
Sherif, S., Hendi, N. N., & Alanany, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13595-8.00005-2
Zhu, X., Wang, Y., Liu, Z., Zhang, X., Zhang, S., Pang, B., & Zhu, S. (2025) · Medicine · doi:10.1097/md.0000000000042678
Self-citationWei, F., Ma, Y., Xiang, H., Zhang, X., & Fan, J. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70618
“Nr4a1, a member of the nuclear receptor superfamily related to steroid, thyroid and retinoid receptors, has been implicated in diverse biological processes, including T cell regulation, inflammatory responses, apoptosis and fibrotic pathways [48–50].”
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
Zander, R., & Cui, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00278-7
CD39 defines a cytotoxic tumor-associated NK cell state responsive to NKG2A blockade in lung cancerPreprint
Serger, C., Rebuffet, L., Sandholzer, M., Rackwitz, W., Fusi, I., Herzig, P., Brüggemann, A., Pawlow, C., Chichelnitskiy, E., Hajnal, D., et al. (2026) · bioRxiv · doi:10.1101/2025.08.26.672316
“For instance, NR4A1 drives T cell exhaustion via suppression of AP1-mediated activation (74) , while IRF4 is implicated in both, NK and T cell activation and effector function (75, 76, 104) .”
CD7 drives CD8 T cell exhaustion during chronic viral infection
Reisch, K. M., Scherer, A., Bartell, R., Santana, F., Shao, P., Butler, N. S., & Zander, R. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf283.1625
Wang, A. Z., Bowman-Kirigin, J. A., Desai, R., Kang, L.-I., Patel, P. R., Patel, B., Khan, S. M., Bender, D. E., Marlin, M. C., Liu, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19736402
Self-citationHu, J., zhang, L., Xia, H., Yan, Y., Zhu, X., Sun, F., Sun, L., Li, S., Li, D., Wang, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22617400
Tjärnberg, A., Beheler-Amass, M., Jackson, C. A., Christiaen, L., Gresham, D., & Bonneau, R. (2024) · Figshare · doi:10.6084/m9.figshare.26669286
Tjärnberg, A., Beheler-Amass, M., Jackson, C. A., Christiaen, L., Gresham, D., & Bonneau, R. (2024) · Figshare · doi:10.6084/m9.figshare.26669283
Chen, D., Feng, S., Chen, Z., Weng, Z., Zhang, S., Lin, J., & Wang, Z. (2026) · Journal of Immunology Research · doi:10.1155/jimr/8444562
Sithole, S. T., Ramsey, J. S., Call, M. C., Poole, B. D., Pickett, B. E., & Berges, B. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.18.706531
Li, Y.-N., Sun, H., Ma, J., Zhou, X.-Y., Xie, X., Xie, H., Hou, Y.-H., Dong, H., Zhao, G.-H., Xu, C., et al. (2026) · Parasites & Vectors · doi:10.1186/s13071-026-07302-7
Metadata
- Authors
- Liu, X., Wang, Y., Lu, H., Li, J., Yan, X., Xiao, M., Hao, J., Alekseev, A., Khong, H., Chen, T., Huang, R., Wu, J., Zhao, Q., Wu, Q., Xu, S., Wang, X., Jin, W., Yu, S., Wang, Y., Wei, L., Wang, A., Zhong, B., Ni, L., Liu, X., Nurieva, R., Ye, L., Tian, Q., Bian, X.-W., & Dong, C.
- Affiliations
- Army Medical University (CN)
- Institute for Systems Biology (US)
- Tsinghua University (CN)
- The University of Texas MD Anderson Cancer Center (US)
- Zhongshan Ophthalmic Center, Sun Yat-sen University (CN)
- Wuhan University (CN)
- Corresponding author
- Liu, Xindong
- Liu, Xiaolong
- Bian, Xiu-Wu
- Dong, Chen
- ORCID
- Venue
- Nature
- Published
- 2019-02-27
- Volume
- 567
- Issue
- 7749
- Pages
- 525-529
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6507425
- OpenAlex
- W2916738215
- Cited by
- 533
- References
- 30
- Citations by year
- 2026: 70 · 2025: 98 · 2024: 81 · 2023: 76 · 2022: 58 · 2021: 63 · 2020: 60 · 2019: 26
- FWCI
- 20.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL143520)
- National Cancer Institute (R03CA219760, P30CA016672)
- National Institute of Allergy and Infectious Diseases (R56AI125269, R21AI120012)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- Nur77, T cell tolerance, T cell dysfunction, AP-1, H3K27 acetylation, histone acetylation, transcriptional repression, effector T cell differentiation, regulatory T cells, cancer immunotherapy, chronic viral infection, tumour immunity, epigenetic regulation
- MeSH terms
- Acetylation, Animals, Arenaviridae Infections, Colitis, Female, Gene Expression Regulation, Histones, Immune Tolerance, Immunotherapy, Lymphocytic choriomeningitis virus, Mice, Inbred C57BL, Neoplasms, T-Lymphocytes, Transcription, Genetic, Genome, Transcription Factor AP-1, Epigenesis, Genetic, Cell Line, Tumor, Mice, Nuclear Receptor Subfamily 4, Group A, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review